Welcome to CAR-T & Cellular Therapy Focus, where you can explore the latest updates in this field by haematological disease and therapy type, showcasing expert interviews and discussions, podcasts and e-learning.

CAR-T and other cellular therapies are at the frontier of hematological malignancy research, offering the potential for paradigm-changing new treatments. Although various questions remain open, it is essential that healthcare professionals understand these therapies, including recognizing and managing their toxicities, and when and how to use them.

View all videos

CAR-T & Cellular Therapy

CAR-T & Cellular Therapy

Welcome to CAR-T & Cellular Therapy Focus, where you can explore the latest updates in this field by haematological disease and therapy type, showcasing expert interviews and discussions, podcasts and e-learning.

CAR-T and other cellular therapies are at the frontier of hematological malignancy research, offering the potential for paradigm-changing new treatments. Although various questions remain open, it is essential that healthcare professionals understand these therapies, including recognizing and managing their toxicities, and when and how to use them.

View all videos

Latest CAR-T and Cellular Therapy Videos

View all videos

Key challenges of using the intestinal microbiome as a biomarker

Cellular therapy and SCT in synergy

The intestinal microbiome for evaluating patient response to CAR T-cell therapy

Patient advocacy in the treatment journey

View CAR-T and Cellular Therapy Videos by Disease Area

Multiple Myeloma

Lymphoma

ALL

AML

CLL

Cellular therapy and SCT in synergy

Transplantation as a platform for continuous therapy

MRD testing in acute leukemias, lymphoma and myeloma

The value of MRD testing in transplant-eligible patients

View All Videos

Cellular therapy and SCT in synergy

The intestinal microbiome for evaluating patient response to CAR T-cell therapy

Key challenges of using the intestinal microbiome as a biomarker

Transplantation as a platform for continuous therapy

View All Videos

Education initiatives for CAR T-cell therapy

Flow cytometry vs. molecular methods for MRD testing in acute leukemias

What clinicians need to know about MRD testing for acute leukemias

MRD testing in the clinical setting: challenges in practice

View All Videos

Flow cytometry vs. molecular methods for MRD testing in acute leukemias

What clinicians need to know about MRD testing for acute leukemias

MRD testing in the clinical setting: challenges in practice

The benefits of dual-targeting triplebodies

View All Videos

Key population-based registry studies in hematological oncology

An exciting time for CAR T-cell therapy: promising results for B-ALL, nHL and CLL

Combining novel agents for CLL to achieve deep remissions: time-limited therapy, treatment cessation & drug re-use in relapse

IciCLLe extension: ibrutinib and obinutuzumab for clears MRD in R/R CLL

View All Videos

Podcasts

Listen to the latest news in I-O from international experts.

Explore the current landscape and future questions surrounding the role of I-O in hematological oncology.

View CAR-T and Cellular Therapy Videos by Topic

Nursing

Clinical Practice

Policy

Treatment

Toxicity

Manufacturing

Education and training for nurses

The EBMT Nurses Group and the patient advocacy track

The role of the nurse clinician in the management of GvHD

Patient monitoring following CAR T-cell therapy

View All Videos

Intensive care for CAR-T: bridge to treatment and response

Learnings from a CAR-T center: leukapheresis, bridging therapy, toxicities & more

European LeukemiaNet 2017 AML recommendations: impact on risk stratification and survival

Improving the accuracy of Waldenström’s prognosis

View All Videos

CAR T-cell therapy economics in the real world

The importance of registering CAR T-cell patient data

EBMT CAR T-cell priorities

The importance of EBMT-EHA in European CAR T-cell therapy

View All Videos

The success story of bispecific and trispecific antibodies

Challenges in the treatment of CMV

Education and training for nurses

Cellular therapy and SCT in synergy

View All Videos

The need for patient advocates to attend major congresses such as EBMT

The patient registry for monitoring long term safety of novel therapies

Anti-BCMA CAR T-cell therapy for multiple myeloma: latest studies

Out of specification CAR T-cells

View All Videos

The benefits of dual-targeting triplebodies

Triplebody development process

Triplebodies for AML: origin, rationale & development

Hellstrand lab leukemia research: exploring immune escape and defining therapeutic targets

View All Videos

e-Learning Coming Soon…

Keep up to date with the latest understanding of CAR-T and other cellular therapies, including use in clinical trials, adoption in the clinic, controversies and cutting-edge research.

This informative and accessible course will answer the most prevalent questions surrounding this therapy, as well as looking at its future potential.

Register Interest

View CAR-T and Cellular Therapy Videos by Therapy Type

CAR T-Cell Therapy

NK-Cell Therapy

Cellular therapy and SCT in synergy

The intestinal microbiome for evaluating patient response to CAR T-cell therapy

Key challenges of using the intestinal microbiome as a biomarker

Patient advocacy in the treatment journey

View All Videos

Are CAR NK-cells the future of CLL therapy?

Immuno-oncology agents for MM: checkpoint inhibitors and NK-cells

CAR T-cells vs. CAR NK-cells

10 years of researching NK-cells for MM treatment

View All Videos